Fundraising Fox

Inbiomotion

4 known investors

InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.

BiotechDigital HealthMedical Devices

Founders & leadership

Board

PR
Prof Rob E. ColemanChairman

Investors · 4

Criteria Bio VenturesBarcelona
Ysios CapitalBarcelona · $5.4M – $21.6M
Alta Life SciencesreportedBarcelona
Asabys PartnersreportedMadrid

In the news

Inbiomotion raises an oversubscribed financing round to launch its diagnostic product in breast cancer – Ysios Capitalysioscapital.com · Jan 2021Inbiomotion raises 2M€ from la Caixa and Ysios Capital – Ysios Capitalysioscapital.com · Mar 2016

Frequently asked questions

What does Inbiomotion do?
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
Who are Inbiomotion's investors?
Inbiomotion's investors include Criteria Bio Ventures, Ysios Capital, Alta Life Sciences, Asabys Partners.